About Us  |  Contact Us
Woman And Infants
Women's Choice Award 2015
Woman And Infants

Trial of AMG 386, A Selective Angiopoietin 1/2 Neutralizing Peptibody

Organizations Women & Infants
Research Type Clinical
Therapeutic Area of Study Cancer - Ovarian
Recruitment Status Open
Contact Information



A Phase II Trial of AMG 386 (IND#111071), A Selective Angiopoietin 1/2 Neutralizing Peptibody, in Patients with Persistent/Recurrent Carcinoma of the Endometrium

Look for another study
Care New England
© 2015 Site Index | Disclaimer | Legal Notices | Talks Your Health